Harbor Osmosis Emerging Markets Resource Efficient ETF (EFFE)

GL...

Apparently George doesn’t know the difference between EAG and CHM.

Ya ya good idea,keep buying this Scam.Chukkky remember the counter says its doubling in price in about 2 months lol

"Divy was an OTC ploy to get buyers. "
Methinks that is correct. NSAV did that in 2017.

https://www.globenewswire.com/news-release/2017/04/24/1087928/0/en/NSAV-Announces-10-Stock-Dividend-and-June-1-Record-Date.html
NSAV Announces 10% Stock Dividend and June 1 Record Dat

Stonkmaster just talked to him around June 2nd or 3rd.

Krisgo, I did get a follow up from GZ after the email from MHRA, I sent to GZ and DI my email from MHRA.



"Thank you for clarifying for your investor peers what we've pretty much been telling everyone all along: the CHM just provides advice, it does not make decisions

Has the merger with Wertheim been completed? Lmao

You are literally the only person left who believes that (or pretends to).

Does anyone know what happened to the Secret Plan?
(Asking for a friend)

https://featureassets.gocomics.com/assets/0a63ee302714013fc072005056a9545d?optimizer=image&width=1200&quality=85

https://featureassets.gocomics.com/assets/0a63ee302714013fc072005056a9545d?optimizer=image&width=1200&quality=85

I'll tell you exactly why I tend to trust their analysis. They recommended Voyager Digital at ~.50 when they signed a marketing contract with them. The stock then went to ~$30 over the next 1.5-2 years. Voyager offered another contract and the NIA refused bc of what they saw in their most recent fin

With LunarD on our side, we Fly tomorrow

11, 77, 19, 38

Johnydollar.

You're absolutely right that DBMM is fighting organically. And I respect that framing. But here's the reality that organic growth runs into every single time:

Growth requires capital. Capital requires a share price that makes fundraising viable. And a share

No, patent approval (or notification) is expected before EOY 26. I think it's generally been a 31/2 - 4 year process and that began January 2023 for US. So we're 3 1/2 years and counting. Of course when / if patent approval, we will still need FDA approval but hopes are that it will be more quic

What does that have to do with where they are and what they are doing? Why do they need to be out of EM ?  
It makes a LOT of sense why they are still in EM.  

Hard worker good you mowed and saw mom get rested!

So you have a problem with their analysis? What specifically in what I posted do you find laughable or simply not possible? I don't do the whole fallacy thing.

I thought you only worked Monday through Friday

Is n't full patent approval 12-24 months away? Best we can hope for is notice of allowance by end of the year.

I agree. Still waiting to hear anything good regarding Amarin's direction and future. The old saying 'can't win for losing' certainly applies to Amarin. So, the LR patent, positive EMT2 as well as Recordati and Edding in China are the things we can hold to for now.

OK, let me be more direct. Speaking for myself, I couldn't in good faith post anything from NIA. I wouldn't trust it as evidence of anything other than proof there's a lot of garbage peddled on the internet. I fail to see how citing NIA strengthens any argument or serves any purpose other than as

When you combine revenues for full year 2025 from Bristol Meyer & Pfizer (joint distribution agreement), we get: $5.1B for Pfizer and $10.2B for Bristol Meyer.
That gives us roughly $15B total transfer market today. About double my initial estimate and roughly half of what IQVIA states from y